209 related articles for article (PubMed ID: 26249215)
1. CD109 is a novel marker for squamous cell/adenosquamous carcinomas of the gallbladder.
Dong F; Lu C; Chen X; Guo Y; Liu J
Diagn Pathol; 2015 Aug; 10():137. PubMed ID: 26249215
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of syndecan-1 and syndecan-2 expression in gallbladder squamous cell/adenosquamous carcinoma and adenocarcinoma].
Tan XG; Yang ZL; Miao XY; Liu ZR; Li DQ; Zou Q; Li JH; Liang LF
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):28-34. PubMed ID: 29365414
[No Abstract] [Full Text] [Related]
3. Paxillin and carbonic anhydrase IX are prognostic markers in gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.
Liu Z; Yang Z; Jiang S; Zou Q; Yuan Y; Li J; Li D; Liang L; Chen M; Chen S
Histopathology; 2014 Jun; 64(7):921-34. PubMed ID: 24354963
[TBL] [Abstract][Full Text] [Related]
4. CFL1 and Arp3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinomas of gallbladder.
Yang ZL; Miao X; Xiong L; Zou Q; Yuan Y; Li J; Liang L; Chen M; Chen S
Cancer Invest; 2013 Feb; 31(2):132-9. PubMed ID: 23320827
[TBL] [Abstract][Full Text] [Related]
5. Squamous cell/adenosquamous carcinomas and adenocarcinomas of the gallbladder: an immunohistochemistry study of prognostic markers.
Li J; Yang ZL; Zou Q; Yuan Y; Li J; Liang L; Zhen G; Chen S
Pathol Oncol Res; 2014 Apr; 20(2):285-92. PubMed ID: 24078426
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma.
Ye BG; Sun HC; Zhu XD; Chai ZT; Zhang YY; Ao JY; Cai H; Ma DN; Wang CH; Qin CD; Gao DM; Tang ZY
Oncotarget; 2016 May; 7(20):29333-45. PubMed ID: 27121053
[TBL] [Abstract][Full Text] [Related]
7. DDR2 and IFITM1 Are Prognostic Markers in Gallbladder Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas.
Li D; Yang Z; Liu Z; Zou Q; Yuan Y
Pathol Oncol Res; 2019 Jan; 25(1):157-167. PubMed ID: 29043607
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas.
Roa JC; Tapia O; Cakir A; Basturk O; Dursun N; Akdemir D; Saka B; Losada H; Bagci P; Adsay NV
Mod Pathol; 2011 Aug; 24(8):1069-78. PubMed ID: 21532545
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
Yuan Y; Yang ZL; Zou Q; Li JH; Li DQ; Liang LF; Zeng GX; Chen SL
Neoplasma; 2013; 60(6):698-705. PubMed ID: 23906305
[TBL] [Abstract][Full Text] [Related]
10. The Expression of Notch 1 and Notch 3 in Gallbladder Cancer and Their Clinicopathological Significance.
Liu L; Yang ZL; Wang C; Miao X; Liu Z; Li D; Zou Q; Li J; Liang L; Zeng G; Chen S
Pathol Oncol Res; 2016 Jul; 22(3):483-92. PubMed ID: 26634853
[TBL] [Abstract][Full Text] [Related]
11. Squamous and adenosquamous cell carcinomas of the gallbladder.
Mingoli A; Brachini G; Petroni R; Antoniozzi A; Cavaliere F; Simonelli L; Chirletti P; Modini C
J Exp Clin Cancer Res; 2005 Mar; 24(1):143-50. PubMed ID: 15943044
[TBL] [Abstract][Full Text] [Related]
12. CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.
Yokoyama M; Ichinoe M; Okina S; Sakurai Y; Nakada N; Yanagisawa N; Jiang SX; Numata Y; Umezawa A; Miyazaki K; Higashihara M; Murakumo Y
Int J Hematol; 2017 May; 105(5):614-622. PubMed ID: 28032275
[TBL] [Abstract][Full Text] [Related]
13. CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.
Mo XT; Leung TH; Tang HW; Siu MK; Wan PK; Chan KK; Cheung AN; Ngan HY
Br J Cancer; 2020 Sep; 123(5):833-843. PubMed ID: 32507856
[TBL] [Abstract][Full Text] [Related]
14. Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas.
Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Otuski Y; Kobayashi H; Nakayama S; Miyazaki K
Hum Pathol; 2012 Apr; 43(4):506-19. PubMed ID: 21889186
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of CBS and CCL21 in Gallbladder Adenocarcinomas and Squamous Cell/Adenosquamous Carcinomas.
Li D; Yang Z; Liu Z; Zou Q; Yuan Y
Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):103-110. PubMed ID: 32044878
[TBL] [Abstract][Full Text] [Related]
16. The clinicopathological significance of Jagged1 and DLL4 in gallbladder cancer.
Luo Y; Yang ZL; Wang C; Miao X; Liu Z; Li D; Zou Q; Li J; Liang L; Zeng G; Chen S
Tumori; 2017 Nov; 103(6):557-565. PubMed ID: 27174628
[TBL] [Abstract][Full Text] [Related]
17. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.
Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M
Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683
[TBL] [Abstract][Full Text] [Related]
18. Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression.
Hagikura M; Murakumo Y; Hasegawa M; Jijiwa M; Hagiwara S; Mii S; Hagikura S; Matsukawa Y; Yoshino Y; Hattori R; Wakai K; Nakamura S; Gotoh M; Takahashi M
Pathol Int; 2010 Nov; 60(11):735-43. PubMed ID: 20946523
[TBL] [Abstract][Full Text] [Related]
19. ACO2 and ANPEP as novel prognostic markers for gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.
Liu Z; Yang Z; Xiong L; Li D; Zou Q; Yuan Y
Int J Clin Oncol; 2020 Jul; 25(7):1346-1355. PubMed ID: 32249333
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of CD109 expression is associated with carcinogenesis of the squamous epithelium of the oral cavity.
Hagiwara S; Murakumo Y; Sato T; Shigetomi T; Mitsudo K; Tohnai I; Ueda M; Takahashi M
Cancer Sci; 2008 Oct; 99(10):1916-23. PubMed ID: 19016750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
